The Effect of Combination of Red and White Bahman Retrieved of Iranian Traditional Medicine on Semen Parameters in Idiopathic Oligospermic Men

Infertility, Male Clinical Trial

Official title:

Effect of Red and White Bahman on Semen Parameters,Testosteron ,LH, FSH and Defragmentation of DNA . A Double Blind Randomised Clinical Trial (Phase 3)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02998593
• Other study ID #: Royan-Emb-026
• Status: Recruiting
• Phase: Phase 3
• First received: November 9, 2016
• Last updated: April 26, 2017
• Start date: July 2016
• Est. completion date: June 2017

Study information

• Verified date: October 2016
• Source: Royan Institute
• Contact: Nasser Aghdami, MD,PhD
• Phone: (+98)23562000
• Email: nasser.aghdami[@]royaninstitute.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is a prospective double blind randomized controlled trial to investigate the effect of red and white bahman on semen parameters, sexual hormones and DNA defragmentation in idiopathic oligospermic men .Include patients will take the medicine and placebo in different two case and control groups for 3 month and semen parameters and other variants at the start and end of study.

Description:

This is a randomized, double blind; placebo-controlled clinical trial has been started from july 2016 and will continue to july 2016 in Royan institute. The eligible patients who fulfilled the study criteria will be included in the trial.

Study protocol and assays All the patients will have a complete history evaluation and physical examination by the attending urologist who is blinded to the study and enter the study according to inclusion criteria.. semen analysis and hormonal laboratory tests [Testosterone, Luteinizing hormone (LH) Follicle stimulating hormone(FSH)] will done in same lab at start of study and 3 month after. Intervention time is 3 month for each patient. semen analysis wil be done according to who laboratory manual for the examination and processing of human semen 5th edition and hormonal tests (LH,FSH,Testosterone) with Elisa method (with score of International Unit). DNA Defragmentation will evaluate with Sperm Chromatin Structure Assay(SCSA) method. semen parameters which will evaluate is the number of normal and abnormal shape sperms, velocity of sperms, volume and viscosity of semen at start and end of the study. medicine and placebo prescribe in 500mg capsules for 3month. red and white Bahman is an effective medicine in male infertility treatment In Iranian Traditional Medicine. at the end of study main aim of the study is evaluation effect of combination of Red and White Bahman retrieved of Iranian Traditional Medicine on Semen Parameters in Idiopathic Oligospermic . Red Bahman and White bahman ,nutrition ,placebo, smoking and Testosterone,LH,FSH,Concentration,number,sha-pe,of sperm before and after the study is variables of study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: June 2017
• Est. primary completion date: April 2017
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 20 Years to 45 Years

Eligibility

Inclusion Criteria:

1. all idiopathic oligospermic patient in range of 20 to 45 years old

2. sperm count under 15 million /ml 3;No history of taking chemical or herbal medicine effective on sperm genesis in last 3 month( like Hormonal drug ,antidepressant ,anti hypertension,cimetidine, cyproteron, sulphasalazine, flutamide, spironolactone, estrogen,opium 4:No history of Varicocele and Obstructive disease 5:;No leukocytospermia

Exclusion Criteria:

Taking chemical or herbal medicine effective on spermatogenesis (hormonal and sperm reducing and increasing agent); 2. ; Increasing BMI > 30 3. Leukocytospermia 4. varicocele

Related Conditions & MeSH terms

• Infertility
• Infertility, Male

Intervention

Drug:
• Bahman capsules
Oral Use of Bahman capsules for 3 months by patients.
• Placebo
Oral use of placebo capsules by patients for 3 months.

Locations

Country	Name	City	State
Iran, Islamic Republic of	Royan Institute	Tehran

Sponsors (1)

Lead Sponsor	Collaborator
Royan Institute

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Semen analysis	Performing the semen analysis to evaluate the sperm count ,sperm motility and sperm morphology.	3 months
Secondary	Testosterone	Evaluation the testosterone by ELISA level 3 months after intervention.	3 months
Secondary	FSH	Evaluation the FSH level by ELISA 3 months after intervention.	3 months
Secondary	LH	Evaluation the LH level by ELISA 3 months after intervention.	3 months
Secondary	DNA defragmentation	Evaluation the DNA defragmentation by SCSA Method 3 months after intervention.	3 months

External Links

•   Link